Nasal mucosa
Nasal mucosa

Juvenile angiofibroma

Definition:
A benign growth of the back of the nose or upper throat (nasopharynx) that contains many blood vessels.

Alternative Names:
Nasal tumor; Angiofibroma - juvenile; Benign nasal tumor

Causes, incidence, and risk factors:
Juvenile angiofibroma is relatively uncommon. It typically is discovered in adolescent boys and is associated with nasal obstruction a visible nasal mass and nosebleeds (epistaxis). The tumor is locally invasive and capable of eroding bone.
Symptoms:
Signs and tests:
Angiofibroma may be visible on examination of the nasopharynx.
Treatment:
Treatment is required if the angiofibroma is enlarging, obstructing the airway, or causing chronicnosebleeds. In some cases, no treatment is necessary.

Surgical treatment includes removal of the tumor. Removal is often difficult because the tumor is unencapsulated and may be deeply invasive. Recurrence of the tumor after surgical resection is common.

Clotting of the vessels of the tumor (embolization) may cause the tumor to scar and stop bleeding. Embolization is performed by injecting a substance into the blood vessel to block blood flow through it. Embolization may be adequate by itself to correct the nosebleeds, or it may be followed by surgery to remove the tumor.
Expectations (prognosis):
Although not cancerous, angiofibromas may continue to expand. They may disappear spontaneously. There is a high rate of recurrence after surgical removal.
Complications:
  • expansion of the angiofibroma to the nose, the sinuses, and other structures
  • anemia from chronicblood loss
  • pressure on the brain from expansion of the angiofibroma (rare)
Calling your health care provider:
Call your health care provider if repeated or frequent nosebleeds occur.
Prevention:
There is no known way to prevent this condition.

Review Date: 12/2/2001
Reviewed By: Jonathan Fanaroff, M.D., Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.